💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @otcdynamics | 7 |
| @TradeWithAlerts | 5 |
| @sleekoptions | 5 |
| @sbwcws | 4 |
| @Allstocknews | 2 |
Recent Tweets for ALKS
 |
@JBMGStockTrades $ALKS weekly. https://t.co/krmq23rHNE April 19th 2021, 2:04pm |
 |
@Allstocknews $ALKS New Form 4 for Alkermes plc From our Stock News Alerts App April 16th 2021, 8:04pm |
 |
@StockTexts $ALKS Alkermes plc SEC Filing: Form 4 https://t.co/TUJodZ55kW April 16th 2021, 8:04pm |
 |
@fintel_io Insider Hopkinson Craig C. reports selling 28,920 shares of $ALKS for a total cost of $570,287.94 https://t.co/yquWk8Kg6o April 16th 2021, 8:04pm |
 |
@formwhisperscom #FWSells $ALKS Hopkinson Craig C., EVP R&D, Chief Medical Officer of Alkermes plc. sold 28,920 shares on 2021-04-15. https://t.co/U2aerG4v2s April 16th 2021, 8:04pm |
 |
@otcdynamics $ALKS This Alcohol Awareness Month, Reevaluate Your Relationship With Alcohol https://t.co/EmODAW6Zc1 April 16th 2021, 5:04pm |
|
@otcdynamics $ALKS Alkermes Shares Immuno Oncology Clinical Trial Research https://t.co/xmSPxXHfQ5 April 15th 2021, 6:04pm |
 |
@SwingTradeBot $ALKS technical alerts: Pocket Pivot, MACD Bullish Signal Line Cross, Crossed Above 200 DMA, 50 D... https://t.co/LZXCqc9JTR April 15th 2021, 12:04pm |
|
@otcdynamics $ALKS Alkermes Celebrates National Minority Health Month https://t.co/96rAaDCm9e April 14th 2021, 8:04pm |
 |
@TradeWithAlerts Large Print $ALKS Size: 353033 Price: 19.23 Time: 1600 Amount: $6,788,824.59 April 14th 2021, 8:04pm |
 |
@sleekoptions $ALKS stock was down -1.70%. Turned Positive 0.43% | (Red to green move) #RedToGreen See other red to green mov… https://t.co/43XV11Gsgb April 14th 2021, 12:04am |
|
@TradeWithAlerts Large Print $ALKS Size: 142537 Price: 18.86 Time: 1600 Amount: $2,688,247.82 April 13th 2021, 8:04pm |
|
@TradeWithAlerts Large Print $ALKS Size: 205560 Price: 18.78 Time: 1600 Amount: $3,860,416.80 April 12th 2021, 8:04pm |
|
@otcdynamics $ALKS Alkermes Provides Resources for Talking to a Loved One About Alcohol Dependence https://t.co/0rqnzdYLPB April 12th 2021, 4:04pm |
|
@sleekoptions Peak profit for the last 6 expired option alerts for $ALKS -86.67% | 19.79% | 60.00% | 37.93% | 30.66% | 25.87% |… https://t.co/JLybOu7mfp April 12th 2021, 2:04pm |
|
@sleekoptions $ALKS - Last six months, 4 option alerts peaked above 100% after they were triggered by the algo… https://t.co/tWcmKDZl7T April 12th 2021, 2:04pm |
|
@sleekoptions $ALKS - View historical options performance for ALKS https://t.co/8OWl95LwVV https://t.co/QEYFBuVnjO April 12th 2021, 2:04pm |
 |
@DataTrials $ALKS Phase 3 A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1…NCT026343… https://t.co/cGoqjKEdHp April 12th 2021, 11:04am |
 |
@OliveDrabGreen RT @MarketChmln: $ALKS option volume was 10X normal on Friday with 7,095 contracts. Call volume was 100% and put volume was 0%. https://t.c… April 12th 2021, 2:04am |
 |
@MarketChmln $ALKS option volume was 10X normal on Friday with 7,095 contracts. Call volume was 100% and put volume was 0%. https://t.co/QANnuvSrC2 April 10th 2021, 7:04pm |
|
@sleekoptions $ALKS Was up 1.52 %. Turned negative -0.16% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/zqTqSxFkR7 April 10th 2021, 1:04am |
|
@TradeWithAlerts Large Print $ALKS Size: 342570 Price: 19.02 Time: 1600 Amount: $6,515,681.40 April 9th 2021, 8:04pm |
|
@otcdynamics $ALKS How Posting About Alcohol May Be Hurting Those Having Trouble Coping With the Pandemic https://t.co/696egyVY4c April 8th 2021, 6:04pm |
 |
@sbwcws Alkermes collaboration not as big as investors wanted, says H.C. Wainwright $ALKS $MRK April 8th 2021, 10:04am |
|
@sbwcws Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin $ALKS $MRK April 7th 2021, 7:04pm |
|
@otcdynamics $ALKS Alkermes Celebrates World Health Day 2021 https://t.co/YmHeOe0fXe April 7th 2021, 6:04pm |
 |
@newsfilterio Alkermes and Merck team up for late-stage ovarian cancer study $ALKS $MRK https://t.co/fKZJ9WIcIT April 7th 2021, 5:04pm |
|
@SwingTradeBot 200 DMA Support today: $ALKS $CMCM ... https://t.co/LjP7KUcNnp April 7th 2021, 3:04pm |
 |
@tradingfitgirl $ALKS $MRK Alkermes and Merck team up for late-stage ovarian cancer study April 7th 2021, 2:04pm |
 |
@Briefingcom $ALKS: Alkermes entered into a clinical trial collaboration and supply agreement with Merck (MRK) for a planned... https://t.co/ttzXVLrGgN April 7th 2021, 1:04pm |
 |
@IOInvestors $ALKS +5.2% (entered into a clinical trial collaboration and supply agreement with Merck (MRK) for a planned phase… https://t.co/gAy7kaF2FL April 7th 2021, 12:04pm |
 |
@OpenOutcrier $ALKS (+5.2% pre) Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvale… https://t.co/rDribbtHtQ April 7th 2021, 12:04pm |
|
@OliveDrabGreen RT @sbwcws: Alkermes enters trial collaboration, supply agreement with MSD $ALKS $MRK April 7th 2021, 11:04am |
|
@otcdynamics $ALKS Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in… https://t.co/pKaBYh9X9s April 7th 2021, 11:04am |
|
@sbwcws Alkermes announces nemvaleukin trial collaboration, supply agreement with Merck $ALKS $MRK April 7th 2021, 11:04am |
|
@Allstocknews $ALKS Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin A From our Stock News Alerts App April 7th 2021, 11:04am |
 |
@Beeken_health $ALKS - Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa… https://t.co/uzStG5UHZy April 7th 2021, 11:04am |
|
@sbwcws Alkermes enters trial collaboration, supply agreement with MSD $ALKS $MRK April 7th 2021, 11:04am |
 |
@stock_titan $ALKS Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in… https://t.co/gLFvR1hFb2 April 7th 2021, 11:04am |
|
@TradeWithAlerts Large Print $ALKS Size: 160824 Price: 19.11 Time: 1600 Amount: $3,073,346.64 April 6th 2021, 8:04pm |
 |
@SnupSnus This??is a very good read, (the table as noted in the article is not exhaustive for IL-2 projects) but $ALKS maybe… https://t.co/Zj0MuspNEm April 6th 2021, 12:04pm |
 |
@ChartMill $ALKS has a bad technical rating, but it does show a decent setup pattern. https://t.co/0BagJCHrHb https://t.co/x6bpWtwwVs April 4th 2021, 3:04am |
 |
@hadidy_sara ALKS: Signal on the 1-minute chart for $ALKS. Trading this is easy with the right algo to help. Get access to Ultra… https://t.co/7OjPP014f6 April 2nd 2021, 11:04pm |
|
@sleekoptions Peak profit for the last 6 expired option alerts for $ALKS -86.67% | 19.79% | 60.00% | 37.93% | 30.66% | 25.87% |… https://t.co/VH7cPzONJ3 April 2nd 2021, 4:04pm |
|
@sleekoptions $ALKS - Last six months, 4 option alerts peaked above 100% after they were triggered by the algo… https://t.co/wK0BzdQLN2 April 2nd 2021, 4:04pm |
|
@sleekoptions $ALKS - View historical options performance for ALKS https://t.co/8OWl95LwVV https://t.co/iXJRCNwPiq April 2nd 2021, 3:04pm |
|
@sleekoptions $ALKS stock was down -1.02%. Turned Positive 2.52% | (Red to green move) #RedToGreen See other red to green mov… https://t.co/aR9McJkAew April 2nd 2021, 3:04am |
|
@TradeWithAlerts Large Print $ALKS Size: 120749 Price: 19.15 Time: 1600 Amount: $2,312,343.35 April 1st 2021, 8:04pm |
|
@sleekoptions $ALKS stock trading volume up by +114.61% | 1,249,802 vs 582,353 https://t.co/pMbOV4NoOw March 31st 2021, 10:03pm |
|
@hadidy_sara ALKS: Signals could not be any clearer on the 1-min chart for $ALKS when with the entry / exit indicators. Get a fr… https://t.co/c7QKkGfIxR March 31st 2021, 9:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
